Clinical Trial Update: Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe Gastroenteritis

View source ↗

Summary

A clinical trial evaluating the Rotarix rotavirus vaccine in children aged 12 weeks to under 5 years hospitalized for severe gastroenteritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• Rotarix (Rotavirus vaccine (live attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Status: WITHDRAWN